Copyright Reports & Markets. All rights reserved.

Global Amlodipine Besylate Sales Market Report 2021

Request for Sample of this report
Buy now

1 Amlodipine Besylate Market Overview

  • 1.1 Amlodipine Besylate Product Scope
  • 1.2 Amlodipine Besylate Segment by Type
    • 1.2.1 Global Amlodipine Besylate Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 2.5mg Tablets
    • 1.2.3 5mg Tablets
    • 1.2.4 10mg Tablets
  • 1.3 Amlodipine Besylate Segment by Application
    • 1.3.1 Global Amlodipine Besylate Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 High Blood Pressure
    • 1.3.3 Heart Disease
  • 1.4 Amlodipine Besylate Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Amlodipine Besylate Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Amlodipine Besylate Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Amlodipine Besylate Price Trends (2016-2027)

2 Amlodipine Besylate Estimates and Forecasts by Region

  • 2.1 Global Amlodipine Besylate Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Amlodipine Besylate Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Amlodipine Besylate Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Amlodipine Besylate Revenue Market Share by Region (2016-2021)
  • 2.3 Global Amlodipine Besylate Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Amlodipine Besylate Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Amlodipine Besylate Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Amlodipine Besylate Estimates and Projections (2016-2027)
    • 2.4.2 Europe Amlodipine Besylate Estimates and Projections (2016-2027)
    • 2.4.3 China Amlodipine Besylate Estimates and Projections (2016-2027)
    • 2.4.4 Japan Amlodipine Besylate Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Amlodipine Besylate Estimates and Projections (2016-2027)
    • 2.4.6 India Amlodipine Besylate Estimates and Projections (2016-2027)

3 Global Amlodipine Besylate Competition Landscape by Players

  • 3.1 Global Top Amlodipine Besylate Players by Sales (2016-2021)
  • 3.2 Global Top Amlodipine Besylate Players by Revenue (2016-2021)
  • 3.3 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2020)
  • 3.4 Global Amlodipine Besylate Average Price by Company (2016-2021)
  • 3.5 Manufacturers Amlodipine Besylate Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Amlodipine Besylate Market Size by Type

  • 4.1 Global Amlodipine Besylate Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Amlodipine Besylate Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Amlodipine Besylate Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Amlodipine Besylate Price by Type (2016-2021)
  • 4.2 Global Amlodipine Besylate Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Amlodipine Besylate Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Amlodipine Besylate Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Amlodipine Besylate Price Forecast by Type (2022-2027)

5 Global Amlodipine Besylate Market Size by Application

  • 5.1 Global Amlodipine Besylate Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Amlodipine Besylate Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Amlodipine Besylate Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Amlodipine Besylate Price by Application (2016-2021)
  • 5.2 Global Amlodipine Besylate Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Amlodipine Besylate Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Amlodipine Besylate Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Amlodipine Besylate Price Forecast by Application (2022-2027)

6 North America Amlodipine Besylate Market Facts & Figures

  • 6.1 North America Amlodipine Besylate Sales by Company
    • 6.1.1 North America Amlodipine Besylate Sales by Company (2016-2021)
    • 6.1.2 North America Amlodipine Besylate Revenue by Company (2016-2021)
  • 6.2 North America Amlodipine Besylate Sales Breakdown by Type
    • 6.2.1 North America Amlodipine Besylate Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Amlodipine Besylate Sales Breakdown by Type (2022-2027)
  • 6.3 North America Amlodipine Besylate Sales Breakdown by Application
    • 6.3.1 North America Amlodipine Besylate Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Amlodipine Besylate Sales Breakdown by Application (2022-2027)

7 Europe Amlodipine Besylate Market Facts & Figures

  • 7.1 Europe Amlodipine Besylate Sales by Company
    • 7.1.1 Europe Amlodipine Besylate Sales by Company (2016-2021)
    • 7.1.2 Europe Amlodipine Besylate Revenue by Company (2016-2021)
  • 7.2 Europe Amlodipine Besylate Sales Breakdown by Type
    • 7.2.1 Europe Amlodipine Besylate Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Amlodipine Besylate Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Amlodipine Besylate Sales Breakdown by Application
    • 7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Amlodipine Besylate Market Facts & Figures

  • 8.1 China Amlodipine Besylate Sales by Company
    • 8.1.1 China Amlodipine Besylate Sales by Company (2016-2021)
    • 8.1.2 China Amlodipine Besylate Revenue by Company (2016-2021)
  • 8.2 China Amlodipine Besylate Sales Breakdown by Type
    • 8.2.1 China Amlodipine Besylate Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Amlodipine Besylate Sales Breakdown by Type (2022-2027)
  • 8.3 China Amlodipine Besylate Sales Breakdown by Application
    • 8.3.1 China 174 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 174 Sales Breakdown by Application (2022-2027)

9 Japan Amlodipine Besylate Market Facts & Figures

  • 9.1 Japan Amlodipine Besylate Sales by Company
    • 9.1.1 Japan Amlodipine Besylate Sales by Company (2016-2021)
    • 9.1.2 Japan Amlodipine Besylate Revenue by Company (2016-2021)
  • 9.2 Japan Amlodipine Besylate Sales Breakdown by Type
    • 9.2.1 Japan Amlodipine Besylate Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Amlodipine Besylate Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Amlodipine Besylate Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Amlodipine Besylate Market Facts & Figures

  • 10.1 Southeast Asia Amlodipine Besylate Sales by Company
    • 10.1.1 Southeast Asia Amlodipine Besylate Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Amlodipine Besylate Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Amlodipine Besylate Sales Breakdown by Type
    • 10.2.1 Southeast Asia Amlodipine Besylate Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Amlodipine Besylate Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Amlodipine Besylate Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Amlodipine Besylate Market Facts & Figures

  • 11.1 India Amlodipine Besylate Sales by Company
    • 11.1.1 India Amlodipine Besylate Sales by Company (2016-2021)
    • 11.1.2 India Amlodipine Besylate Revenue by Company (2016-2021)
  • 11.2 India Amlodipine Besylate Sales Breakdown by Type
    • 11.2.1 India Amlodipine Besylate Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Amlodipine Besylate Sales Breakdown by Type (2022-2027)
  • 11.3 India Amlodipine Besylate Sales Breakdown by Application
    • 11.3.1 India Amlodipine Besylate Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Amlodipine Besylate Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Amlodipine Besylate Business

  • 12.1 Pfizer
    • 12.1.1 Pfizer Corporation Information
    • 12.1.2 Pfizer Business Overview
    • 12.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Pfizer Amlodipine Besylate Products Offered
    • 12.1.5 Pfizer Recent Development
  • 12.2 Mylan
    • 12.2.1 Mylan Corporation Information
    • 12.2.2 Mylan Business Overview
    • 12.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Mylan Amlodipine Besylate Products Offered
    • 12.2.5 Mylan Recent Development
  • 12.3 Dr. Reddy's Laboratories
    • 12.3.1 Dr. Reddy's Laboratories Corporation Information
    • 12.3.2 Dr. Reddy's Laboratories Business Overview
    • 12.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Products Offered
    • 12.3.5 Dr. Reddy's Laboratories Recent Development
  • 12.4 Apotex
    • 12.4.1 Apotex Corporation Information
    • 12.4.2 Apotex Business Overview
    • 12.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Apotex Amlodipine Besylate Products Offered
    • 12.4.5 Apotex Recent Development
  • 12.5 Teva Pharmaceutical
    • 12.5.1 Teva Pharmaceutical Corporation Information
    • 12.5.2 Teva Pharmaceutical Business Overview
    • 12.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Teva Pharmaceutical Amlodipine Besylate Products Offered
    • 12.5.5 Teva Pharmaceutical Recent Development
  • 12.6 Cipla
    • 12.6.1 Cipla Corporation Information
    • 12.6.2 Cipla Business Overview
    • 12.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Cipla Amlodipine Besylate Products Offered
    • 12.6.5 Cipla Recent Development
  • 12.7 Hikma Pharmaceuticals
    • 12.7.1 Hikma Pharmaceuticals Corporation Information
    • 12.7.2 Hikma Pharmaceuticals Business Overview
    • 12.7.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Hikma Pharmaceuticals Amlodipine Besylate Products Offered
    • 12.7.5 Hikma Pharmaceuticals Recent Development
  • 12.8 Strides Pharma
    • 12.8.1 Strides Pharma Corporation Information
    • 12.8.2 Strides Pharma Business Overview
    • 12.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Strides Pharma Amlodipine Besylate Products Offered
    • 12.8.5 Strides Pharma Recent Development
  • 12.9 Upsher-Smith Laboratories
    • 12.9.1 Upsher-Smith Laboratories Corporation Information
    • 12.9.2 Upsher-Smith Laboratories Business Overview
    • 12.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Upsher-Smith Laboratories Amlodipine Besylate Products Offered
    • 12.9.5 Upsher-Smith Laboratories Recent Development
  • 12.10 InvaGen Pharmaceuticals
    • 12.10.1 InvaGen Pharmaceuticals Corporation Information
    • 12.10.2 InvaGen Pharmaceuticals Business Overview
    • 12.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Products Offered
    • 12.10.5 InvaGen Pharmaceuticals Recent Development
  • 12.11 Sun Pharmaceutical
    • 12.11.1 Sun Pharmaceutical Corporation Information
    • 12.11.2 Sun Pharmaceutical Business Overview
    • 12.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Sun Pharmaceutical Amlodipine Besylate Products Offered
    • 12.11.5 Sun Pharmaceutical Recent Development
  • 12.12 Aurobindo Pharma
    • 12.12.1 Aurobindo Pharma Corporation Information
    • 12.12.2 Aurobindo Pharma Business Overview
    • 12.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Aurobindo Pharma Amlodipine Besylate Products Offered
    • 12.12.5 Aurobindo Pharma Recent Development
  • 12.13 Lupin Pharmaceuticals
    • 12.13.1 Lupin Pharmaceuticals Corporation Information
    • 12.13.2 Lupin Pharmaceuticals Business Overview
    • 12.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Lupin Pharmaceuticals Amlodipine Besylate Products Offered
    • 12.13.5 Lupin Pharmaceuticals Recent Development
  • 12.14 Zydus Pharmaceuticals
    • 12.14.1 Zydus Pharmaceuticals Corporation Information
    • 12.14.2 Zydus Pharmaceuticals Business Overview
    • 12.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Zydus Pharmaceuticals Amlodipine Besylate Products Offered
    • 12.14.5 Zydus Pharmaceuticals Recent Development
  • 12.15 Oxford Pharm
    • 12.15.1 Oxford Pharm Corporation Information
    • 12.15.2 Oxford Pharm Business Overview
    • 12.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Oxford Pharm Amlodipine Besylate Products Offered
    • 12.15.5 Oxford Pharm Recent Development
  • 12.16 Wockhardt
    • 12.16.1 Wockhardt Corporation Information
    • 12.16.2 Wockhardt Business Overview
    • 12.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Wockhardt Amlodipine Besylate Products Offered
    • 12.16.5 Wockhardt Recent Development
  • 12.17 Epic Pharma
    • 12.17.1 Epic Pharma Corporation Information
    • 12.17.2 Epic Pharma Business Overview
    • 12.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Epic Pharma Amlodipine Besylate Products Offered
    • 12.17.5 Epic Pharma Recent Development
  • 12.18 CR Pharmaceutical
    • 12.18.1 CR Pharmaceutical Corporation Information
    • 12.18.2 CR Pharmaceutical Business Overview
    • 12.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 CR Pharmaceutical Amlodipine Besylate Products Offered
    • 12.18.5 CR Pharmaceutical Recent Development
  • 12.19 Alkem Laboratories
    • 12.19.1 Alkem Laboratories Corporation Information
    • 12.19.2 Alkem Laboratories Business Overview
    • 12.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Alkem Laboratories Amlodipine Besylate Products Offered
    • 12.19.5 Alkem Laboratories Recent Development
  • 12.20 MACLEODS
    • 12.20.1 MACLEODS Corporation Information
    • 12.20.2 MACLEODS Business Overview
    • 12.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2016-2021)
    • 12.20.4 MACLEODS Amlodipine Besylate Products Offered
    • 12.20.5 MACLEODS Recent Development

13 Amlodipine Besylate Manufacturing Cost Analysis

  • 13.1 Amlodipine Besylate Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Amlodipine Besylate
  • 13.4 Amlodipine Besylate Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Amlodipine Besylate Distributors List
  • 14.3 Amlodipine Besylate Customers

15 Market Dynamics

  • 15.1 Amlodipine Besylate Market Trends
  • 15.2 Amlodipine Besylate Drivers
  • 15.3 Amlodipine Besylate Market Challenges
  • 15.4 Amlodipine Besylate Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Amlodipine Besylate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Amlodipine Besylate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    2.5mg Tablets
    5mg Tablets
    10mg Tablets

    Segment by Application
    High Blood Pressure
    Heart Disease

    The Amlodipine Besylate market is analysed and market size information is provided by regions (countries). Segment by Application, the Amlodipine Besylate market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Pfizer
    Mylan
    Dr. Reddy's Laboratories
    Apotex
    Teva Pharmaceutical
    Cipla
    Hikma Pharmaceuticals
    Strides Pharma
    Upsher-Smith Laboratories
    InvaGen Pharmaceuticals
    Sun Pharmaceutical
    Aurobindo Pharma
    Lupin Pharmaceuticals
    Zydus Pharmaceuticals
    Oxford Pharm
    Wockhardt
    Epic Pharma
    CR Pharmaceutical
    Alkem Laboratories
    MACLEODS

    Buy now